+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Female Contraceptive Market - Global Forecast 2026-2032- Product Image
Female Contraceptive Market - Global Forecast 2026-2032- Product Image
New

Female Contraceptive Market - Global Forecast 2026-2032

  • PDF Icon

    Report

  • 187 Pages
  • January 2026
  • Region: Global
  • 360iResearch™
  • ID: 4904506
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The female contraceptive market is undergoing significant transformation, shaped by ongoing clinical advancements, rising expectations for personalized solutions, and the evolving role of digital healthcare. Senior decision-makers require strategic insight into these drivers to navigate future growth with confidence.

Market Snapshot: Female Contraceptive Market Growth Trends

The female contraceptive market expanded from USD 10.57 billion in 2025 to USD 11.28 billion in 2026 and is projected to reach USD 17.53 billion by 2032, representing a CAGR of 7.49%. This sustained growth is attributable to persistent demand for innovative, accessible contraceptive solutions across various geographies and distribution channels. As the market becomes more multifaceted, manufacturers and distributors are recalibrating their approach to address shifting user preferences and emerging clinical challenges in established and developing regions alike.

Scope & Segmentation

  • Product Types: Implants, injectables, intrauterine devices (IUDs), oral pills, patches, rings, and novel combination therapies address diverse clinical requirements and expand user choice, supporting adaptation to regional differences in medical practice and consumer expectations.
  • Contraceptive Mechanisms: Hormonal (including combined and progestin-only), non-hormonal, and hybrid modalities provide an extensive spectrum of choices for both providers and end-users. This versatility is critical for meeting individualized health needs and overcoming barriers to long-term adherence.
  • Age-Based User Segments: Serving women in the 15–24, 25–34, and 35–49 age groups ensures solutions that align with varied health behaviors, life stages, and demand for counseling or recurring services.
  • Distribution Channels: Products are accessed through clinics, hospital pharmacies, retail outlets, and online platforms, each shaping user access and repeat purchase patterns. The rise of digital and at-home dispensing is accelerating changes in recurring use and aftercare.
  • Geographical Coverage: Americas, Europe/Middle East/Africa (EMEA), and Asia-Pacific markets each present unique regulatory and infrastructure challenges, necessitating regionally nuanced go-to-market and compliance strategies.
  • Technology Integration: Integration of digital adherence tools, telehealth counseling, direct-to-consumer distribution, and supply chain management platforms enhances operational efficiency, supports patient engagement, and enables more responsive service models to improve outcomes across user populations.

Key Takeaways for Senior Decision-Makers

  • Greater emphasis on long-acting and user-controlled solutions is prompting companies to update portfolio strategies and speed adaptation timelines to stay ahead of evolving patient expectations.
  • Continuous improvements in device design and active formulations expand clinical options and contribute to better user experience and safety, creating strong opportunities for product refreshes and market expansion.
  • Digital health and telemedicine are rapidly broadening service access, facilitating personalized counseling and simplifying repeat prescription models, which require organizations to rethink distribution and engagement frameworks.
  • Increased focus on regulatory and reimbursement compliance, particularly on real-world evidence, is reshaping investment priorities. Integrated, comprehensive care models are gaining influence in both public and private sectors.
  • Supply sourcing and distribution resilience have gained prominence with global disruptions, making contingency-driven procurement and supplier diversification essential for uninterrupted product delivery.
  • Differentiated regulatory environments and healthcare infrastructures across key markets require localized evidence, market entry approaches, and service deployment models to support sustained uptake and secure regional market position.

Tariff Impact: Considerations for Supply Strategy

Recent changes in global trade policies and tariffs have significantly influenced cost structures and sourcing considerations for market stakeholders. These adjustments have heightened the complexity of supplier management, compelling manufacturers and distributors to adopt strategies such as nearshoring, diversification, and enhanced customs navigation. A proactive focus on regional production facilities and comprehensive contingency planning now supports resilient supply and mitigates the risk of operational interruption in an unpredictable economic environment.

Methodology & Data Sources

This report utilizes a rigorously structured research approach. Primary insights were gathered from in-depth interviews with clinicians, procurement executives, and distribution specialists. These firsthand perspectives were supplemented by secondary research, which included thorough literature reviews, regulatory document analysis, and supply chain data audits. Triangulation of multiple data points ensured that the findings are both robust and actionable for industry leadership.

Why This Report Matters

  • Provides senior executives with a precise and data-backed overview of the clinical, commercial, and regulatory landscape shaping the female contraceptive market.
  • Delivers relevant strategic guidance for market expansion, investment selection, and optimization of channel management within a complex and evolving environment.
  • Equips organizations to anticipate and respond to emerging supply chain and policy challenges, strengthening their ability to maintain stability and seize new opportunities.

Conclusion

Successfully competing in the female contraceptive marketplace requires a deliberate combination of innovation, operational agility, and user-centric planning. This report delivers strategic insight for leaders seeking growth, resilience, and informed, market-ready action.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Porter’s Five Forces Analysis
4.4. PESTLE Analysis
4.5. Market Outlook
4.5.1. Near-Term Market Outlook (0-2 Years)
4.5.2. Medium-Term Market Outlook (3-5 Years)
4.5.3. Long-Term Market Outlook (5-10 Years)
4.6. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025
8. Female Contraceptive Market, by Product Type
8.1. Implants
8.2. Injectables
8.3. Intrauterine Devices
8.3.1. Copper IUD
8.3.2. Hormonal IUD
8.4. Pills
8.4.1. Combined Pill
8.4.1.1. First Generation
8.4.1.2. Fourth Generation
8.4.1.3. Second Generation
8.4.1.4. Third Generation
8.4.2. Progestin Only Pill
9. Female Contraceptive Market, by Mechanism
9.1. Hormonal
9.1.1. Combined
9.1.2. Progestin Only
9.2. Non-Hormonal
10. Female Contraceptive Market, by End User Age
10.1. 15-24 Years
10.2. 25-34 Years
10.3. 35-49 Years
11. Female Contraceptive Market, by Distribution Channel
11.1. Clinics
11.2. Hospital Pharmacies
11.3. Online Pharmacies
11.4. Retail Pharmacies
12. Female Contraceptive Market, by Region
12.1. Americas
12.1.1. North America
12.1.2. Latin America
12.2. Europe, Middle East & Africa
12.2.1. Europe
12.2.2. Middle East
12.2.3. Africa
12.3. Asia-Pacific
13. Female Contraceptive Market, by Group
13.1. ASEAN
13.2. GCC
13.3. European Union
13.4. BRICS
13.5. G7
13.6. NATO
14. Female Contraceptive Market, by Country
14.1. United States
14.2. Canada
14.3. Mexico
14.4. Brazil
14.5. United Kingdom
14.6. Germany
14.7. France
14.8. Russia
14.9. Italy
14.10. Spain
14.11. China
14.12. India
14.13. Japan
14.14. Australia
14.15. South Korea
15. United States Female Contraceptive Market
16. China Female Contraceptive Market
17. Competitive Landscape
17.1. Market Concentration Analysis, 2025
17.1.1. Concentration Ratio (CR)
17.1.2. Herfindahl Hirschman Index (HHI)
17.2. Recent Developments & Impact Analysis, 2025
17.3. Product Portfolio Analysis, 2025
17.4. Benchmarking Analysis, 2025
17.5. Abbvie Inc.
17.6. Acme Generics Pvt. Ltd.
17.7. Afaxys, Inc.
17.8. Agile Therapeutics, Inc.
17.9. Amneal Pharmaceuticals LLC
17.10. ASKA Pharmaceutical Co., Ltd.
17.11. Aurobindo Pharma Limited
17.12. Bayer AG
17.13. Church & Dwight Co., Inc.
17.14. Cipla Limited
17.15. HLL Lifecare Limited
17.16. Insud Pharma, S.L.
17.17. Johnson & Johnson Services, Inc.
17.18. Lupin Limited
17.19. Mayne Pharma Group Limited
17.20. Merck & Co., Inc.
17.21. Mithra Pharmaceuticals S.A.
17.22. Okamoto Industries, Inc.
17.23. Organon & Co.
17.24. Perrigo Company PLC
17.25. Pfizer Inc.
17.26. Piramal Pharma Ltd.
17.27. Reckitt Benckiser Group PLC
17.28. Ritex GmbH
17.29. Sanofi S.A.
17.30. Say It With A Condom, LLC
17.31. Syzygy Healthcare Solutions LLC
17.32. Teva Pharmaceutical Industries Ltd.
17.33. TherapeuticsMD, Inc.
17.34. TTK Healthcare Limited
17.35. Veru Inc.
17.36. Viatris Inc.
List of Figures
FIGURE 1. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 2. GLOBAL FEMALE CONTRACEPTIVE MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 3. GLOBAL FEMALE CONTRACEPTIVE MARKET, FPNV POSITIONING MATRIX, 2025
FIGURE 4. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 5. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY MECHANISM, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 6. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY END USER AGE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 7. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 9. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 11. UNITED STATES FEMALE CONTRACEPTIVE MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 12. CHINA FEMALE CONTRACEPTIVE MARKET SIZE, 2018-2032 (USD MILLION)
List of Tables
TABLE 1. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 2. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY IMPLANTS, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY IMPLANTS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY IMPLANTS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY INJECTABLES, BY REGION, 2018-2032 (USD MILLION)
TABLE 7. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY INJECTABLES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 8. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY INJECTABLES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY INTRAUTERINE DEVICES, BY REGION, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY INTRAUTERINE DEVICES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY INTRAUTERINE DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY INTRAUTERINE DEVICES, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY COPPER IUD, BY REGION, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY COPPER IUD, BY GROUP, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY COPPER IUD, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY HORMONAL IUD, BY REGION, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY HORMONAL IUD, BY GROUP, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY HORMONAL IUD, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY PILLS, BY REGION, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY PILLS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY PILLS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY PILLS, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY COMBINED PILL, BY REGION, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY COMBINED PILL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY COMBINED PILL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY COMBINED PILL, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY FIRST GENERATION, BY REGION, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY FIRST GENERATION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY FIRST GENERATION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY FOURTH GENERATION, BY REGION, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY FOURTH GENERATION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY FOURTH GENERATION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY SECOND GENERATION, BY REGION, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY SECOND GENERATION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY SECOND GENERATION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY THIRD GENERATION, BY REGION, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY THIRD GENERATION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY THIRD GENERATION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY PROGESTIN ONLY PILL, BY REGION, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY PROGESTIN ONLY PILL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY PROGESTIN ONLY PILL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY MECHANISM, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY HORMONAL, BY REGION, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY HORMONAL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY HORMONAL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY HORMONAL, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY COMBINED, BY REGION, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY COMBINED, BY GROUP, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY COMBINED, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY PROGESTIN ONLY, BY REGION, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY PROGESTIN ONLY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY PROGESTIN ONLY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY NON-HORMONAL, BY REGION, 2018-2032 (USD MILLION)
TABLE 54. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY NON-HORMONAL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 55. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY NON-HORMONAL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 56. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY END USER AGE, 2018-2032 (USD MILLION)
TABLE 57. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY 15-24 YEARS, BY REGION, 2018-2032 (USD MILLION)
TABLE 58. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY 15-24 YEARS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 59. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY 15-24 YEARS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 60. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY 25-34 YEARS, BY REGION, 2018-2032 (USD MILLION)
TABLE 61. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY 25-34 YEARS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 62. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY 25-34 YEARS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 63. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY 35-49 YEARS, BY REGION, 2018-2032 (USD MILLION)
TABLE 64. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY 35-49 YEARS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 65. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY 35-49 YEARS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 66. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 67. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY CLINICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 68. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 69. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 70. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 71. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY HOSPITAL PHARMACIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 72. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY HOSPITAL PHARMACIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 73. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 74. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY ONLINE PHARMACIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 75. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY ONLINE PHARMACIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 76. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 77. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY RETAIL PHARMACIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 78. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY RETAIL PHARMACIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 79. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 80. AMERICAS FEMALE CONTRACEPTIVE MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 81. AMERICAS FEMALE CONTRACEPTIVE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 82. AMERICAS FEMALE CONTRACEPTIVE MARKET SIZE, BY INTRAUTERINE DEVICES, 2018-2032 (USD MILLION)
TABLE 83. AMERICAS FEMALE CONTRACEPTIVE MARKET SIZE, BY PILLS, 2018-2032 (USD MILLION)
TABLE 84. AMERICAS FEMALE CONTRACEPTIVE MARKET SIZE, BY COMBINED PILL, 2018-2032 (USD MILLION)
TABLE 85. AMERICAS FEMALE CONTRACEPTIVE MARKET SIZE, BY MECHANISM, 2018-2032 (USD MILLION)
TABLE 86. AMERICAS FEMALE CONTRACEPTIVE MARKET SIZE, BY HORMONAL, 2018-2032 (USD MILLION)
TABLE 87. AMERICAS FEMALE CONTRACEPTIVE MARKET SIZE, BY END USER AGE, 2018-2032 (USD MILLION)
TABLE 88. AMERICAS FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 89. NORTH AMERICA FEMALE CONTRACEPTIVE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 90. NORTH AMERICA FEMALE CONTRACEPTIVE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 91. NORTH AMERICA FEMALE CONTRACEPTIVE MARKET SIZE, BY INTRAUTERINE DEVICES, 2018-2032 (USD MILLION)
TABLE 92. NORTH AMERICA FEMALE CONTRACEPTIVE MARKET SIZE, BY PILLS, 2018-2032 (USD MILLION)
TABLE 93. NORTH AMERICA FEMALE CONTRACEPTIVE MARKET SIZE, BY COMBINED PILL, 2018-2032 (USD MILLION)
TABLE 94. NORTH AMERICA FEMALE CONTRACEPTIVE MARKET SIZE, BY MECHANISM, 2018-2032 (USD MILLION)
TABLE 95. NORTH AMERICA FEMALE CONTRACEPTIVE MARKET SIZE, BY HORMONAL, 2018-2032 (USD MILLION)
TABLE 96. NORTH AMERICA FEMALE CONTRACEPTIVE MARKET SIZE, BY END USER AGE, 2018-2032 (USD MILLION)
TABLE 97. NORTH AMERICA FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 98. LATIN AMERICA FEMALE CONTRACEPTIVE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 99. LATIN AMERICA FEMALE CONTRACEPTIVE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 100. LATIN AMERICA FEMALE CONTRACEPTIVE MARKET SIZE, BY INTRAUTERINE DEVICES, 2018-2032 (USD MILLION)
TABLE 101. LATIN AMERICA FEMALE CONTRACEPTIVE MARKET SIZE, BY PILLS, 2018-2032 (USD MILLION)
TABLE 102. LATIN AMERICA FEMALE CONTRACEPTIVE MARKET SIZE, BY COMBINED PILL, 2018-2032 (USD MILLION)
TABLE 103. LATIN AMERICA FEMALE CONTRACEPTIVE MARKET SIZE, BY MECHANISM, 2018-2032 (USD MILLION)
TABLE 104. LATIN AMERICA FEMALE CONTRACEPTIVE MARKET SIZE, BY HORMONAL, 2018-2032 (USD MILLION)
TABLE 105. LATIN AMERICA FEMALE CONTRACEPTIVE MARKET SIZE, BY END USER AGE, 2018-2032 (USD MILLION)
TABLE 106. LATIN AMERICA FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 107. EUROPE, MIDDLE EAST & AFRICA FEMALE CONTRACEPTIVE MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 108. EUROPE, MIDDLE EAST & AFRICA FEMALE CONTRACEPTIVE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 109. EUROPE, MIDDLE EAST & AFRICA FEMALE CONTRACEPTIVE MARKET SIZE, BY INTRAUTERINE DEVICES, 2018-2032 (USD MILLION)
TABLE 110. EUROPE, MIDDLE EAST & AFRICA FEMALE CONTRACEPTIVE MARKET SIZE, BY PILLS, 2018-2032 (USD MILLION)
TABLE 111. EUROPE, MIDDLE EAST & AFRICA FEMALE CONTRACEPTIVE MARKET SIZE, BY COMBINED PILL, 2018-2032 (USD MILLION)
TABLE 112. EUROPE, MIDDLE EAST & AFRICA FEMALE CONTRACEPTIVE MARKET SIZE, BY MECHANISM, 2018-2032 (USD MILLION)
TABLE 113. EUROPE, MIDDLE EAST & AFRICA FEMALE CONTRACEPTIVE MARKET SIZE, BY HORMONAL, 2018-2032 (USD MILLION)
TABLE 114. EUROPE, MIDDLE EAST & AFRICA FEMALE CONTRACEPTIVE MARKET SIZE, BY END USER AGE, 2018-2032 (USD MILLION)
TABLE 115. EUROPE, MIDDLE EAST & AFRICA FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 116. EUROPE FEMALE CONTRACEPTIVE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 117. EUROPE FEMALE CONTRACEPTIVE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 118. EUROPE FEMALE CONTRACEPTIVE MARKET SIZE, BY INTRAUTERINE DEVICES, 2018-2032 (USD MILLION)
TABLE 119. EUROPE FEMALE CONTRACEPTIVE MARKET SIZE, BY PILLS, 2018-2032 (USD MILLION)
TABLE 120. EUROPE FEMALE CONTRACEPTIVE MARKET SIZE, BY COMBINED PILL, 2018-2032 (USD MILLION)
TABLE 121. EUROPE FEMALE CONTRACEPTIVE MARKET SIZE, BY MECHANISM, 2018-2032 (USD MILLION)
TABLE 122. EUROPE FEMALE CONTRACEPTIVE MARKET SIZE, BY HORMONAL, 2018-2032 (USD MILLION)
TABLE 123. EUROPE FEMALE CONTRACEPTIVE MARKET SIZE, BY END USER AGE, 2018-2032 (USD MILLION)
TABLE 124. EUROPE FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 125. MIDDLE EAST FEMALE CONTRACEPTIVE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 126. MIDDLE EAST FEMALE CONTRACEPTIVE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 127. MIDDLE EAST FEMALE CONTRACEPTIVE MARKET SIZE, BY INTRAUTERINE DEVICES, 2018-2032 (USD MILLION)
TABLE 128. MIDDLE EAST FEMALE CONTRACEPTIVE MARKET SIZE, BY PILLS, 2018-2032 (USD MILLION)
TABLE 129. MIDDLE EAST FEMALE CONTRACEPTIVE MARKET SIZE, BY COMBINED PILL, 2018-2032 (USD MILLION)
TABLE 130. MIDDLE EAST FEMALE CONTRACEPTIVE MARKET SIZE, BY MECHANISM, 2018-2032 (USD MILLION)
TABLE 131. MIDDLE EAST FEMALE CONTRACEPTIVE MARKET SIZE, BY HORMONAL, 2018-2032 (USD MILLION)
TABLE 132. MIDDLE EAST FEMALE CONTRACEPTIVE MARKET SIZE, BY END USER AGE, 2018-2032 (USD MILLION)
TABLE 133. MIDDLE EAST FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 134. AFRICA FEMALE CONTRACEPTIVE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 135. AFRICA FEMALE CONTRACEPTIVE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 136. AFRICA FEMALE CONTRACEPTIVE MARKET SIZE, BY INTRAUTERINE DEVICES, 2018-2032 (USD MILLION)
TABLE 137. AFRICA FEMALE CONTRACEPTIVE MARKET SIZE, BY PILLS, 2018-2032 (USD MILLION)
TABLE 138. AFRICA FEMALE CONTRACEPTIVE MARKET SIZE, BY COMBINED PILL, 2018-2032 (USD MILLION)
TABLE 139. AFRICA FEMALE CONTRACEPTIVE MARKET SIZE, BY MECHANISM, 2018-2032 (USD MILLION)
TABLE 140. AFRICA FEMALE CONTRACEPTIVE MARKET SIZE, BY HORMONAL, 2018-2032 (USD MILLION)
TABLE 141. AFRICA FEMALE CONTRACEPTIVE MARKET SIZE, BY END USER AGE, 2018-2032 (USD MILLION)
TABLE 142. AFRICA FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 143. ASIA-PACIFIC FEMALE CONTRACEPTIVE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 144. ASIA-PACIFIC FEMALE CONTRACEPTIVE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 145. ASIA-PACIFIC FEMALE CONTRACEPTIVE MARKET SIZE, BY INTRAUTERINE DEVICES, 2018-2032 (USD MILLION)
TABLE 146. ASIA-PACIFIC FEMALE CONTRACEPTIVE MARKET SIZE, BY PILLS, 2018-2032 (USD MILLION)
TABLE 147. ASIA-PACIFIC FEMALE CONTRACEPTIVE MARKET SIZE, BY COMBINED PILL, 2018-2032 (USD MILLION)
TABLE 148. ASIA-PACIFIC FEMALE CONTRACEPTIVE MARKET SIZE, BY MECHANISM, 2018-2032 (USD MILLION)
TABLE 149. ASIA-PACIFIC FEMALE CONTRACEPTIVE MARKET SIZE, BY HORMONAL, 2018-2032 (USD MILLION)
TABLE 150. ASIA-PACIFIC FEMALE CONTRACEPTIVE MARKET SIZE, BY END USER AGE, 2018-2032 (USD MILLION)
TABLE 151. ASIA-PACIFIC FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 152. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 153. ASEAN FEMALE CONTRACEPTIVE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 154. ASEAN FEMALE CONTRACEPTIVE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 155. ASEAN FEMALE CONTRACEPTIVE MARKET SIZE, BY INTRAUTERINE DEVICES, 2018-2032 (USD MILLION)
TABLE 156. ASEAN FEMALE CONTRACEPTIVE MARKET SIZE, BY PILLS, 2018-2032 (USD MILLION)
TABLE 157. ASEAN FEMALE CONTRACEPTIVE MARKET SIZE, BY COMBINED PILL, 2018-2032 (USD MILLION)
TABLE 158. ASEAN FEMALE CONTRACEPTIVE MARKET SIZE, BY MECHANISM, 2018-2032 (USD MILLION)
TABLE 159. ASEAN FEMALE CONTRACEPTIVE MARKET SIZE, BY HORMONAL, 2018-2032 (USD MILLION)
TABLE 160. ASEAN FEMALE CONTRACEPTIVE MARKET SIZE, BY END USER AGE, 2018-2032 (USD MILLION)
TABLE 161. ASEAN FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 162. GCC FEMALE CONTRACEPTIVE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 163. GCC FEMALE CONTRACEPTIVE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 164. GCC FEMALE CONTRACEPTIVE MARKET SIZE, BY INTRAUTERINE DEVICES, 2018-2032 (USD MILLION)
TABLE 165. GCC FEMALE CONTRACEPTIVE MARKET SIZE, BY PILLS, 2018-2032 (USD MILLION)
TABLE 166. GCC FEMALE CONTRACEPTIVE MARKET SIZE, BY COMBINED PILL, 2018-2032 (USD MILLION)
TABLE 167. GCC FEMALE CONTRACEPTIVE MARKET SIZE, BY MECHANISM, 2018-2032 (USD MILLION)
TABLE 168. GCC FEMALE CONTRACEPTIVE MARKET SIZE, BY HORMONAL, 2018-2032 (USD MILLION)
TABLE 169. GCC FEMALE CONTRACEPTIVE MARKET SIZE, BY END USER AGE, 2018-2032 (USD MILLION)
TABLE 170. GCC FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 171. EUROPEAN UNION FEMALE CONTRACEPTIVE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 172. EUROPEAN UNION FEMALE CONTRACEPTIVE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 173. EUROPEAN UNION FEMALE CONTRACEPTIVE MARKET SIZE, BY INTRAUTERINE DEVICES, 2018-2032 (USD MILLION)
TABLE 174. EUROPEAN UNION FEMALE CONTRACEPTIVE MARKET SIZE, BY PILLS, 2018-2032 (USD MILLION)
TABLE 175. EUROPEAN UNION FEMALE CONTRACEPTIVE MARKET SIZE, BY COMBINED PILL, 2018-2032 (USD MILLION)
TABLE 176. EUROPEAN UNION FEMALE CONTRACEPTIVE MARKET SIZE, BY MECHANISM, 2018-2032 (USD MILLION)
TABLE 177. EUROPEAN UNION FEMALE CONTRACEPTIVE MARKET SIZE, BY HORMONAL, 2018-2032 (USD MILLION)
TABLE 178. EUROPEAN UNION FEMALE CONTRACEPTIVE MARKET SIZE, BY END USER AGE, 2018-2032 (USD MILLION)
TABLE 179. EUROPEAN UNION FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 180. BRICS FEMALE CONTRACEPTIVE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 181. BRICS FEMALE CONTRACEPTIVE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 182. BRICS FEMALE CONTRACEPTIVE MARKET SIZE, BY INTRAUTERINE DEVICES, 2018-2032 (USD MILLION)
TABLE 183. BRICS FEMALE CONTRACEPTIVE MARKET SIZE, BY PILLS, 2018-2032 (USD MILLION)
TABLE 184. BRICS FEMALE CONTRACEPTIVE MARKET SIZE, BY COMBINED PILL, 2018-2032 (USD MILLION)
TABLE 185. BRICS FEMALE CONTRACEPTIVE MARKET SIZE, BY MECHANISM, 2018-2032 (USD MILLION)
TABLE 186. BRICS FEMALE CONTRACEPTIVE MARKET SIZE, BY HORMONAL, 2018-2032 (USD MILLION)
TABLE 187. BRICS FEMALE CONTRACEPTIVE MARKET SIZE, BY END USER AGE, 2018-2032 (USD MILLION)
TABLE 188. BRICS FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 189. G7 FEMALE CONTRACEPTIVE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 190. G7 FEMALE CONTRACEPTIVE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 191. G7 FEMALE CONTRACEPTIVE MARKET SIZE, BY INTRAUTERINE DEVICES, 2018-2032 (USD MILLION)
TABLE 192. G7 FEMALE CONTRACEPTIVE MARKET SIZE, BY PILLS, 2018-2032 (USD MILLION)
TABLE 193. G7 FEMALE CONTRACEPTIVE MARKET SIZE, BY COMBINED PILL, 2018-2032 (USD MILLION)
TABLE 194. G7 FEMALE CONTRACEPTIVE MARKET SIZE, BY MECHANISM, 2018-2032 (USD MILLION)
TABLE 195. G7 FEMALE CONTRACEPTIVE MARKET SIZE, BY HORMONAL, 2018-2032 (USD MILLION)
TABLE 196. G7 FEMALE CONTRACEPTIVE MARKET SIZE, BY END USER AGE, 2018-2032 (USD MILLION)
TABLE 197. G7 FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 198. NATO FEMALE CONTRACEPTIVE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 199. NATO FEMALE CONTRACEPTIVE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 200. NATO FEMALE CONTRACEPTIVE MARKET SIZE, BY INTRAUTERINE DEVICES, 2018-2032 (USD MILLION)
TABLE 201. NATO FEMALE CONTRACEPTIVE MARKET SIZE, BY PILLS, 2018-2032 (USD MILLION)
TABLE 202. NATO FEMALE CONTRACEPTIVE MARKET SIZE, BY COMBINED PILL, 2018-2032 (USD MILLION)
TABLE 203. NATO FEMALE CONTRACEPTIVE MARKET SIZE, BY MECHANISM, 2018-2032 (USD MILLION)
TABLE 204. NATO FEMALE CONTRACEPTIVE MARKET SIZE, BY HORMONAL, 2018-2032 (USD MILLION)
TABLE 205. NATO FEMALE CONTRACEPTIVE MARKET SIZE, BY END USER AGE, 2018-2032 (USD MILLION)
TABLE 206. NATO FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 207. GLOBAL FEMALE CONTRACEPTIVE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 208. UNITED STATES FEMALE CONTRACEPTIVE MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 209. UNITED STATES FEMALE CONTRACEPTIVE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 210. UNITED STATES FEMALE CONTRACEPTIVE MARKET SIZE, BY INTRAUTERINE DEVICES, 2018-2032 (USD MILLION)
TABLE 211. UNITED STATES FEMALE CONTRACEPTIVE MARKET SIZE, BY PILLS, 2018-2032 (USD MILLION)
TABLE 212. UNITED STATES FEMALE CONTRACEPTIVE MARKET SIZE, BY COMBINED PILL, 2018-2032 (USD MILLION)
TABLE 213. UNITED STATES FEMALE CONTRACEPTIVE MARKET SIZE, BY MECHANISM, 2018-2032 (USD MILLION)
TABLE 214. UNITED STATES FEMALE CONTRACEPTIVE MARKET SIZE, BY HORMONAL, 2018-2032 (USD MILLION)
TABLE 215. UNITED STATES FEMALE CONTRACEPTIVE MARKET SIZE, BY END USER AGE, 2018-2032 (USD MILLION)
TABLE 216. UNITED STATES FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 217. CHINA FEMALE CONTRACEPTIVE MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 218. CHINA FEMALE CONTRACEPTIVE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 219. CHINA FEMALE CONTRACEPTIVE MARKET SIZE, BY INTRAUTERINE DEVICES, 2018-2032 (USD MILLION)
TABLE 220. CHINA FEMALE CONTRACEPTIVE MARKET SIZE, BY PILLS, 2018-2032 (USD MILLION)
TABLE 221. CHINA FEMALE CONTRACEPTIVE MARKET SIZE, BY COMBINED PILL, 2018-2032 (USD MILLION)
TABLE 222. CHINA FEMALE CONTRACEPTIVE MARKET SIZE, BY MECHANISM, 2018-2032 (USD MILLION)
TABLE 223. CHINA FEMALE CONTRACEPTIVE MARKET SIZE, BY HORMONAL, 2018-2032 (USD MILLION)
TABLE 224. CHINA FEMALE CONTRACEPTIVE MARKET SIZE, BY END USER AGE, 2018-2032 (USD MILLION)
TABLE 225. CHINA FEMALE CONTRACEPTIVE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)

Companies Mentioned

The key companies profiled in this Female Contraceptive market report include:
  • Abbvie Inc.
  • Acme Generics Pvt. Ltd.
  • Afaxys, Inc.
  • Agile Therapeutics, Inc.
  • Amneal Pharmaceuticals LLC
  • ASKA Pharmaceutical Co., Ltd.
  • Aurobindo Pharma Limited
  • Bayer AG
  • Church & Dwight Co., Inc.
  • Cipla Limited
  • HLL Lifecare Limited
  • Insud Pharma, S.L.
  • Johnson & Johnson Services, Inc.
  • Lupin Limited
  • Mayne Pharma Group Limited
  • Merck & Co., Inc.
  • Mithra Pharmaceuticals S.A.
  • Okamoto Industries, Inc.
  • Organon & Co.
  • Perrigo Company PLC
  • Pfizer Inc.
  • Piramal Pharma Ltd.
  • Reckitt Benckiser Group PLC
  • Ritex GmbH
  • Sanofi S.A.
  • Say It With A Condom, LLC
  • Syzygy Healthcare Solutions LLC
  • Teva Pharmaceutical Industries Ltd.
  • TherapeuticsMD, Inc.
  • TTK Healthcare Limited
  • Veru Inc.
  • Viatris Inc.

Table Information

Report AttributeDetails
No. of Pages187
PublishedJanuary 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 11.28 Billion
Forecasted Market Value ( USD ) by 2032 $ 17.53 Billion
Compound Annual Growth Rate7.4%
Regions CoveredGlobal
No. of Companies Mentioned33

Related Topics

Related Reports

Contraceptive Market Overview, 2025-30 - Product Image

Contraceptive Market Overview, 2025-30

  • Report
  • 118 Pages
  • Global
From
Contraceptives Market Report 2025 - Product Image

Contraceptives Market Report 2025

  • Report
  • 250 Pages
  • Global
From
Hormonal Contraceptive Market Report by Product, Hormone, Age Group, End User, and Region 2025-2033 - Product Image

Hormonal Contraceptive Market Report by Product, Hormone, Age Group, End User, and Region 2025-2033

  • Report
  • 145 Pages
  • Global
From
Contraceptive Market Report: Trends, Forecast and Competitive Analysis to 2031 - Product Image

Contraceptive Market Report: Trends, Forecast and Competitive Analysis to 2031

  • Report
  • 150 Pages
  • Global
From
Hormonal Contraceptive Market Report: Trends, Forecast and Competitive Analysis to 2031 - Product Image

Hormonal Contraceptive Market Report: Trends, Forecast and Competitive Analysis to 2031

  • Report
  • 150 Pages
  • Global
From

About the Female Contraceptive Market

The Female Contraceptive market is an important part of Women's Health, providing women with the ability to control their reproductive health. Contraceptives are used to prevent pregnancy, and can be divided into two main categories: hormonal and non-hormonal. Hormonal contraceptives, such as the pill, patch, and ring, use hormones to prevent ovulation and fertilization. Non-hormonal contraceptives, such as condoms, diaphragms, and spermicides, work by blocking sperm from entering the uterus. In addition to preventing pregnancy, contraceptives can also be used to treat a variety of conditions, such as endometriosis, polycystic ovary syndrome, and acne. Contraceptives can also be used to regulate menstrual cycles and reduce the risk of certain cancers. Some companies in the Female Contraceptive market include Bayer, Merck, Pfizer, and Teva Pharmaceuticals. Show Less Read more

Copyright © 2002-2026 Research and Markets. All Rights Reserved.